APO Research
Talk to an analyst

APO RESEARCH · REPORT

Group ACYW135 Meningococcal Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032

29 December 2025104 pages

Choose your research edition.

Industry ResearchGroup ACYW135 Meningococcal Polysaccharide Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Group ACYW135 Meningococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Group ACYW135 Meningococcal Polysaccharide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Group ACYW135 Meningococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Group ACYW135 Meningococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Group ACYW135 Meningococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine include Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Yuxi Watson Biotechnology Co., Ltd, CanSino Biologics AG, Hualan Biovaccine Co., Ltd, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd and Walvax Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Group ACYW135 Meningococcal Polysaccharide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Group ACYW135 Meningococcal Polysaccharide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Group ACYW135 Meningococcal Polysaccharide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Company

Zhejiang Tianyuan Biopharmaceutical Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

CanSino Biologics AG

Hualan Biovaccine Co., Ltd

Chengdu Kanghua Biological Products Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Beijing Institute of Biological Products Co., Ltd

Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd

Walvax Biotechnology

Sanofi-Pasteur

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type

Class I Vaccines

Class II Vaccines

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Group ACYW135 Meningococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Group ACYW135 Meningococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Class I Vaccines Table 2. Major Company of Class II Vaccines Table 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends Table 25. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Drivers Table 26. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 27. Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Restraints Table 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Company (2021-2026) Table 32. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Major Company Production Sites and Headquarters Table 35. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company, Product Type & Application Table 36. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Group ACYW135 Meningococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Company Information Table 72. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Business Overview Table 73. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 75. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Development Table 76. Yuxi Watson Biotechnology Co., Ltd Company Information Table 77. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 78. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 80. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 81. CanSino Biologics AG Company Information Table 82. CanSino Biologics AG Business Overview Table 83. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 85. CanSino Biologics AG Recent Development Table 86. Hualan Biovaccine Co., Ltd Company Information Table 87. Hualan Biovaccine Co., Ltd Business Overview Table 88. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 90. Hualan Biovaccine Co., Ltd Recent Development Table 91. Chengdu Kanghua Biological Products Co., Ltd Company Information Table 92. Chengdu Kanghua Biological Products Co., Ltd Business Overview Table 93. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 95. Chengdu Kanghua Biological Products Co., Ltd Recent Development Table 96. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 97. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 98. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 100. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Development Table 101. Beijing Institute of Biological Products Co., Ltd Company Information Table 102. Beijing Institute of Biological Products Co., Ltd Business Overview Table 103. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 105. Beijing Institute of Biological Products Co., Ltd Recent Development Table 106. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Company Information Table 107. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Business Overview Table 108. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 110. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Development Table 111. Walvax Biotechnology Company Information Table 112. Walvax Biotechnology Business Overview Table 113. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 115. Walvax Biotechnology Recent Development Table 116. Sanofi-Pasteur Company Information Table 117. Sanofi-Pasteur Business Overview Table 118. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio Table 120. Sanofi-Pasteur Recent Development Table 121. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 123. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 124. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 129. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 131. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 133. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 134. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 139. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 149. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 151. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 153. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 154. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 159. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 169. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List Table 174. Group ACYW135 Meningococcal Polysaccharide Vaccine Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Image Figure 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 5. Class I Vaccines Image Figure 6. Global Class I Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Class II Vaccines Image Figure 8. Global Class II Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Group ACYW135 Meningococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Group ACYW135 Meningococcal Polysaccharide Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Group ACYW135 Meningococcal Polysaccharide Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Class I Vaccines
  • Class II Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhejiang Tianyuan Biopharmaceutical Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd
  • CanSino Biologics AG
  • Hualan Biovaccine Co., Ltd
  • Chengdu Kanghua Biological Products Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
  • Walvax Biotechnology
  • Sanofi-Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Type
  6. 1.3.1 Class I Vaccines
  7. 1.3.2 Class II Vaccines
  8. 1.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
  9. 1.4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Group ACYW135 Meningococcal Polysaccharide Vaccine Price (2021-2026)
  4. 3.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company, Product Type & Application
  7. 3.7 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Group ACYW135 Meningococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Group ACYW135 Meningococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Group ACYW135 Meningococcal Polysaccharide Vaccine Regional Status and Outlook
  1. 4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historic Market Size by Region
  3. 4.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Group ACYW135 Meningococcal Polysaccharide Vaccine by Application
  1. 5.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
  5. 5.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
  2. 6.1.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Company Information
  3. 6.1.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Business Overview
  4. 6.1.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  6. 6.1.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments
  7. 6.2 Yuxi Watson Biotechnology Co., Ltd
  8. 6.2.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  9. 6.2.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  10. 6.2.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  12. 6.2.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  13. 6.3 CanSino Biologics AG
  14. 6.3.1 CanSino Biologics AG Company Information
  15. 6.3.2 CanSino Biologics AG Business Overview
  16. 6.3.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  18. 6.3.5 CanSino Biologics AG Recent Developments
  19. 6.4 Hualan Biovaccine Co., Ltd
  20. 6.4.1 Hualan Biovaccine Co., Ltd Company Information
  21. 6.4.2 Hualan Biovaccine Co., Ltd Business Overview
  22. 6.4.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  24. 6.4.5 Hualan Biovaccine Co., Ltd Recent Developments
  25. 6.5 Chengdu Kanghua Biological Products Co., Ltd
  26. 6.5.1 Chengdu Kanghua Biological Products Co., Ltd Company Information
  27. 6.5.2 Chengdu Kanghua Biological Products Co., Ltd Business Overview
  28. 6.5.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  30. 6.5.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments
  31. 6.6 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  32. 6.6.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  33. 6.6.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  34. 6.6.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  36. 6.6.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  37. 6.7 Beijing Institute of Biological Products Co., Ltd
  38. 6.7.1 Beijing Institute of Biological Products Co., Ltd Company Information
  39. 6.7.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  40. 6.7.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  42. 6.7.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
  43. 6.8 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
  44. 6.8.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Company Information
  45. 6.8.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Business Overview
  46. 6.8.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  48. 6.8.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments
  49. 6.9 Walvax Biotechnology
  50. 6.9.1 Walvax Biotechnology Company Information
  51. 6.9.2 Walvax Biotechnology Business Overview
  52. 6.9.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  54. 6.9.5 Walvax Biotechnology Recent Developments
  55. 6.10 Sanofi-Pasteur
  56. 6.10.1 Sanofi-Pasteur Company Information
  57. 6.10.2 Sanofi-Pasteur Business Overview
  58. 6.10.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
  60. 6.10.5 Sanofi-Pasteur Recent Developments
7 North America by Country
  1. 7.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
  2. 7.1.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 7.2.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
  2. 8.1.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 8.2.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
  2. 10.1.1 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 10.2.1 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Value Chain Analysis
  2. 12.1.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Mode & Process
  7. 12.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors
  10. 12.2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst